Trials / Completed
CompletedNCT06354556
Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects
Effect of Verapamil on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects: a Single Center, Open, Single Arm, and Fixed Sequence Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this phase Ⅰ study is to evaluate the effect of oral verapamil tablets on the pharmacokinetics of HRS-1893 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1893 tablet | HRS-1893 tablet single dose |
| DRUG | Verapamil tablet | Verapamil tablet 80 mg tid |
Timeline
- Start date
- 2024-04-26
- Primary completion
- 2024-05-20
- Completion
- 2024-05-20
- First posted
- 2024-04-09
- Last updated
- 2024-06-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06354556. Inclusion in this directory is not an endorsement.